ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,040.04
1.10%
Dow Jones
43,297.03
0.91%
US Dollar vs MXN
20.1642
-0.03%
Brent Oil
73.285
0.00%
Bitcoin
98,056.50
-0.63%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Chimerix Inc (CMRX)

  7. Chimerix Inc (CMRX) Noticias

Chimerix Inc

Chimerix Inc (CMRX)

NASDAQ
3.34
0.32
(10.60%)
Cerrado 24 Diciembre 3:00PM
Delayed by 15 minutes
3.30
-0.04
(-1.20%)
Fuera de horario: 4:00PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

CMRX Noticias

Solo noticias oficiales

Form 8-K - Current report
Edgar (US Regulatory)
10 Diciembre 2024
CMRX (10.60%)

Form 8-K - Current report
Edgar (US Regulatory)
14 Noviembre 2024
CMRX (10.60%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
07 Noviembre 2024
CMRX (10.60%)

Form 8-K - Current report
Edgar (US Regulatory)
07 Noviembre 2024
CMRX (10.60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
30 Octubre 2024
CMRX (10.60%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
13 Agosto 2024
CMRX (10.60%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 Agosto 2024
CMRX (10.60%)

CMRX Discussion

Ver más
bikaver bikaver 4 días hace
CMRX.....bought in @ 2.93.....could see another leg up!
👍️0
glenn1919 glenn1919 2 semanas hace
CMRX.........................................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 semanas hace
CMRX..............https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783
🏦 1 ✅️ 1
SantaZar SantaZar 2 semanas hace
$CMRX - Gain: 217% #DDAmanda Video Analysis - #1 Stock Screener / Scanner

#DDAmanda Christmas Special Signup:

https://ddamanda.com/SignUpXMAS.php

Questions/Support: 760 702-2009 - Hans@DDAmanda.com



Z
👍️0
dablitz dablitz 2 semanas hace
Congrat's to those those who had a good day here today.
👍️0
Invest-in-America Invest-in-America 2 semanas hace
CMRX: Another article about it ---
https://finance.yahoo.com/news/why-cancer-focused-chimerix-stock-143934294.html
👍️0
georgie18 georgie18 2 semanas hace
CMRX...All out in the $3.10 range...🥳Beauty flip...from $2.02 range...

georgie18

Member Level
Re: georgie18 post# 667358

Tuesday, December 10, 2024 9:45:48 AM

Post#
667376
of 667379
CMRX...$2.71...🥳...Volume...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 386753

Tuesday, December 10, 2024 8:14:24 AM

Post#
386761
of 386773
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
👍️0
georgie18 georgie18 2 semanas hace
CMRX...$2.71...🥳...Volume...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 386753

Tuesday, December 10, 2024 8:14:24 AM

Post#
386761
of 386773
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
👍️0
georgie18 georgie18 2 semanas hace
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
👍️0
glenn1919 glenn1919 2 semanas hace
CMRX.............................https://stockcharts.com/h-sc/ui?s=CRMX&p=W&b=5&g=0&id=p86431144783
👍️ 1 💲 1
Invest-in-America Invest-in-America 2 semanas hace
CMRX: Soaring!!! Likely $3-4 bucks in the Post-M!!!
👍️0
glenn1919 glenn1919 2 semanas hace
CMRX.......................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 2 semanas hace
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
👍️0
georgie18 georgie18 2 semanas hace
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
👍 1
pzottkpz pzottkpz 1 mes hace
⏰⏰⏰⏰⏰⏰⏰⏰⏰⏰

can this hold a buck if markets correct
or will they have to do something to maintain listing

💲CMRX
👍️0
Monksdream Monksdream 4 meses hace
CMRX new 52 week low
👍️0
mick mick 1 año hace
GBIM
Globelmmune Inc (CE)
0.0002
0.00 (0.00%)
Volume:
👍️0
mick mick 1 año hace
GBIM
Globelmmune Inc (CE)
0.0002
0.00 (0.00%)
Volume:
👍️0
Monksdream Monksdream 1 año hace
CMRX new 52 low
👍️0
Monksdream Monksdream 1 año hace
CMRX new 52 week low
👍️0
Monksdream Monksdream 1 año hace
CMRX new 52 week low
👍️0
kzivann kzivann 2 años hace
Thanks, saw that but neglected to post news.

CMRX
👍️0
db7 db7 2 años hace
https://www.businesswire.com/news/home/20221110005658/en/
👍️0
kzivann kzivann 2 años hace
More good news.

CMRX
👍️0
kzivann kzivann 2 años hace
News looks good.

CMRX
👍️0
kzivann kzivann 2 años hace
Nice news. Got some.

CMRX
👍️0
weedtrader420 weedtrader420 2 años hace
WEEEEEEEEE
👍️0
weedtrader420 weedtrader420 2 años hace
Monday fun here CMRX$ WOW! Monkey pox vaccine
👍️0
weedtrader420 weedtrader420 2 años hace
$5 coming
👍️0
mcjodie mcjodie 2 años hace
Looking good
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX$
👍️0
db7 db7 2 años hace
from the EBS earnings call transcript:

"
Unidentified Analyst

This is Nick on for Boris. So I just have a quick question about Chimerix and TEMBEXA. So previously, the -- right pretty much right after you guys announced this acquisition of TEMBEXA, they said that the BARDA contract was likely to take place within the next couple of weeks or months, and now it's pushed back. And I just wanted to know if you guys had any reasoning behind this or any information as to why it's been pushed back, especially with monkeypox and now being declared a public health emergency, you kind of think that it may be pushed forward, but it seems to be just pushed back a little bit more.

Bob Kramer

Yes. Thanks, Nick, for the question. Thanks for joining the call. So a couple of comments. As I commented on my prepared remarks, the HSR process and the waiting period for this expired last Friday. So now that, I think, gives BARDA and Chimerix kind of the green light to finalize the BARDA procurement agreement, which then gives us the clear path to closing the transaction and moving forward.

I wouldn't read anything into the perhaps perceived delay in getting the contract awarded. Obviously, BARDA is looking at this very carefully and they are aware that our interest in acquiring the product from Chimerix. So I think, again, there's momentum to get this done, and we're anxious to get done as well

"
👍️0
db7 db7 2 años hace
my hope is that the BARDA negotiation is to 'upsize' the original contract that was discussed(?)
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX$$$$$$$$ WOOHOOOOOO
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX$ $5 TARGET
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX$Surfin USA
👍️0
db7 db7 2 años hace
interesting if we get BARDA announcement this week; per last extension due 'soon'
👍️0
Trend22 Trend22 2 años hace
CMRX - Nice news and nice pre market!
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX$
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX SIGA $$$$$$$$$$$$
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX$
👍️0
weedtrader420 weedtrader420 2 años hace
Now we’re moving WOOHOOOOOO CMRX$$$$$$$$$$$$$$SIGA
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX SIGA Upchurch HI-DEAS 2 $$$$$$$$$$$
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX $10 TARGET PRICE WOOHOOOOOO
👍️0
weedtrader420 weedtrader420 2 años hace
BUYING BUYING BUYING
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX$
👍️0
weedtrader420 weedtrader420 2 años hace
Monkeypox is spreading all over America
👍️0
weedtrader420 weedtrader420 2 años hace
Government is going to lose control of Monkeypox it’s about to spread
👍️0
weedtrader420 weedtrader420 2 años hace
CMRX $4 target price today
👍️0
db7 db7 2 años hace
like this one and surprised that it's just sitting here around $2; potential for multibagger imo


g/l
👍️0

Su Consulta Reciente

NASDAQ
CMRX
Chimerix
AQSE
GBCH.GB
WisdomTree Commodity Sec...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados